Skip to main content

Ocugen, Inc.

OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001372299

In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Ocugen, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of OCGN: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders114103−11
Shares90.0M62.4M−27.7M (−30.7%)
Value$117.0M$53.2M−$63.8M (−54.5%)

New holders (18)

Institutions that held Ocugen, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to OCGN in Q1 2023
InstitutionSharesValue% of portfolio
Ergoteles LLC1,516,801$1.29M0.05%
Millennium Management LLC1,267,682$1.08M0.00%
HRT Financial LP1,007,728$859.0K0.01%
Centiva Capital, LP237,500$201.9K0.01%
Y-Intercept (Hong Kong) Ltd221,791$189.2K0.02%
ExodusPoint Capital Management, LP209,442$179.0K0.00%
Cubist Systematic Strategies, LLC179,115$152.8K0.00%
Point72 Asset Management, L.P.159,005$135.6K0.00%
Simplex Trading, LLC126,659$108.0K0.00%
Laurion Capital Management LP49,778$42.5K0.00%
Marshall Wace, LLP38,260$32.5K0.00%
Winton Group Ltd29,296$25.0K0.00%
Baldwin Investment Management, LLC22,500$19.2K0.00%
Sawtooth Solutions, LLC13,960$11.9K0.00%
HighTower Advisors, LLC10,300$9.00K0.00%
Brown, Lisle/Cummings, Inc.2,000$1.71K0.00%
Farther Finance Advisors, LLC500$4270.00%
Northwestern Mutual Wealth Management Co100$850.00%

Sold out (29)

Institutions that held Ocugen, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.